Illumina Inc. (ILMN): Price and Financial Metrics

Illumina Inc. (ILMN): $218.08

9.51 (+4.56%)

POWR Rating

Component Grades













Add ILMN to Watchlist
Sign Up

Industry: Biotech



in industry


  • ILMN scores best on the Growth dimension, with a Growth rank ahead of 51.42% of US stocks.
  • ILMN's strongest trending metric is Quality; it's been moving down over the last 179 days.
  • ILMN ranks lowest in Momentum; there it ranks in the 8th percentile.

ILMN Stock Summary

  • ILMN has a market capitalization of $34,119,943,000 -- more than approximately 93.18% of US stocks.
  • The price/operating cash flow metric for ILLUMINA INC is higher than 93.52% of stocks in our set with a positive cash flow.
  • Over the past twelve months, ILMN has reported earnings growth of -449.31%, putting it ahead of only 3.74% of US stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to ILLUMINA INC are KN, IFF, NVTA, KOS, and HES.
  • ILMN's SEC filings can be seen here. And to visit ILLUMINA INC's official web site, go to

ILMN Valuation Summary

  • ILMN's price/earnings ratio is -8.3; this is 135.78% lower than that of the median Healthcare stock.
  • Over the past 243 months, ILMN's EV/EBIT ratio has gone down 4.6.

Below are key valuation metrics over time for ILMN.

Stock Date P/S P/B P/E EV/EBIT
ILMN 2022-11-25 7.3 5.1 -8.3 -8.9
ILMN 2022-11-23 7.4 5.2 -8.4 -9.0
ILMN 2022-11-22 7.4 5.2 -8.4 -9.0
ILMN 2022-11-21 7.5 5.2 -8.5 -9.1
ILMN 2022-11-18 7.4 5.2 -8.4 -8.9
ILMN 2022-11-17 7.5 5.3 -8.5 -9.1

ILMN Growth Metrics

    Its 3 year cash and equivalents growth rate is now at -40.48%.
  • The year over year cash and equivalents growth rate now stands at -69.52%.
  • Its 2 year price growth rate is now at -4.63%.
Over the past 15 months, ILMN's revenue has gone up $733,000,000.

The table below shows ILMN's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 4,699 527 -4,153
2022-06-30 4,692 307 -20
2022-03-31 4,656 435 700
2021-12-31 4,526 545 762
2021-09-30 4,280 669 906
2021-06-30 3,966 1,094 768

ILMN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ILMN has a Quality Grade of B, ranking ahead of 94.64% of graded US stocks.
  • ILMN's asset turnover comes in at 0.489 -- ranking 48th of 75 Measuring and Control Equipment stocks.
  • AMOT, AATC, and TRMB are the stocks whose asset turnover ratios are most correlated with ILMN.

The table below shows ILMN's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-07-04 0.489 0.686 0.187
2021-04-04 0.448 0.676 0.175
2021-01-03 0.439 0.680 0.173
2020-09-27 0.443 0.690 0.165
2020-06-28 0.464 0.703 0.174
2020-03-29 0.497 0.704 0.209

ILMN Price Target

For more insight on analysts targets of ILMN, see our ILMN price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $459.00 Average Broker Recommendation 1.92 (Hold)

ILMN Stock Price Chart Interactive Chart >

Price chart for ILMN

ILMN Price/Volume Stats

Current price $218.08 52-week high $428.00
Prev. close $208.57 52-week low $173.45
Day low $203.32 Volume 2,519,700
Day high $218.60 Avg. volume 1,327,491
50-day MA $213.78 Dividend yield N/A
200-day MA $245.05 Market Cap 34.30B

Illumina Inc. (ILMN) Company Bio

Illumina, Inc. is an American company. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencinggenotyping and gene expression, and proteomics markets. Its headquarters are located in San Diego, California. (Source:Wikipedia)

ILMN Latest News Stream

Event/Time News Detail
Loading, please wait...

ILMN Latest Social Stream

Loading social stream, please wait...

View Full ILMN Social Stream

Latest ILMN News From Around the Web

Below are the latest news stories about ILLUMINA INC that investors may wish to consider to help them evaluate ILMN as an investment opportunity.

Video: Increasing Genomic Capability in the United Arab Emirates

Emirati scientists, clinicians, and dignitaries attended the opening of the Illumina Solutions Center in Dubai on November 8.

Yahoo | November 29, 2022

10 Best Biotech Stocks To Buy According To Hedge Funds

In this article, we discuss 10 best biotech stocks to buy according to hedge funds. If you want to see more stocks in this selection, check out 5 Best Biotech Stocks To Buy According To Hedge Funds. In 2023, digitalization will increase in the biotech industry as the possibility of online and remote assessment, diagnosis, […]

Yahoo | November 25, 2022

Addressing the Shortage of Genetic Counselors With Software

NORTHAMPTON, MA / ACCESSWIRE / November 21, 2022 / Illumina: Nearly everyone is a carrier for some kind of genetic disorder.1 (Probably even you.) Being a carrier means you inherited an abnormal copy of a gene from one parent, but you show no symptoms ...

Yahoo | November 21, 2022

Q&A With the CTO: Storing Growing Data While Reducing Environmental Impact

NORTHAMPTON, MA / ACCESSWIRE / November 18, 2022 / As the UN Climate Change Conference (COP27) convenes this month in Sharm el-Sheikh, Egypt, Sharon Vidal, global head of Corporate Social Responsibility at Illumina, talks to the company''s chief technology officer, Alex Aravanis, about achieving a sustainable future with intelligent data storage solutions that reduce Illumina''s environmental footprint. Vidal: The volume of data associated with the growing field of genomics is increasing data storage needs, as well as the costs and carbon footprint that go with it. What is Illumina doing to address these issues? Aravanis: The amount of data generated from next-generation sequencing is rapidly expanding. To reach the full potential of genomics in health care, we need not only accessible ...

Accesswire | November 18, 2022

The Illumina Inc. (ILMN) had a good session last reading, didn’t it?

Illumina Inc. (NASDAQ:ILMN) closed Thursday at $224.68 per share, down from $231.79 a day earlier. While Illumina Inc. has underperformed by -3.07%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, ILMN fell by -40.50%, with highs and lows ranging from $428.00 to $173.45, whereas the simple […]

US Post News | November 18, 2022

Read More 'ILMN' Stories Here

ILMN Price Returns

1-mo -0.48%
3-mo 11.23%
6-mo -6.39%
1-year -39.03%
3-year -31.78%
5-year -3.18%
YTD -42.68%
2021 2.82%
2020 11.53%
2019 10.61%
2018 37.27%
2017 70.64%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.864 seconds.